Marie-laure Arcangeli

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

ZMAT3 alleviates cell death in Fanconi anemia via adaptation of sphingolipid metabolism.

ZMAT3 alleviates cell death in Fanconi anemia via adaptation of sphingolipid metabolism.

Journal: Science advances
Published: July 31, 2026

Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.

Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.

Journal: Experimental hematology & oncology
Published: July 09, 2025

GATA 2 much: stemness and resistance in AML chemotherapy.

GATA 2 much: stemness and resistance in AML chemotherapy.

Journal: Blood
Published: May 08, 2025

In vivo deletion of a GWAS-identified Myb distal enhancer acts on Myb expression, globin switching, and clinical erythroid parameters in β-thalassemia.

In vivo deletion of a GWAS-identified Myb distal enhancer acts on Myb expression, globin switching, and clinical erythroid parameters in β-thalassemia.

Journal: Scientific reports
Published: January 13, 2025

MDM4 overexpression alleviates developmental and hematopoietic defects in Fancg deficient mice.

MDM4 overexpression alleviates developmental and hematopoietic defects in Fancg deficient mice.

Journal: Leukemia
Published: July 29, 2024

Progressive chromatin rewiring by ETO2::GLIS2 revealed in a genome-edited human iPSC model of pediatric leukemia initiation.

Progressive chromatin rewiring by ETO2::GLIS2 revealed in a genome-edited human iPSC model of pediatric leukemia initiation.

Journal: Blood
Published: March 01, 2024

The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions.

The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions.

Journal: Stem cells translational medicine
Published: January 04, 2023

From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis.

From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis.

Journal: Bulletin du cancer
Published: November 16, 2022

Reprogramming monocyte-derived macrophages through caspase inhibition.

Reprogramming monocyte-derived macrophages through caspase inhibition.

Journal: Oncoimmunology
Published: March 07, 2022

REDD1 is a gatekeeper of murine hematopoietic stem cell functions during stress responses.

REDD1 is a gatekeeper of murine hematopoietic stem cell functions during stress responses.

Journal: Leukemia
Published: February 23, 2022

JAM-C/Jam-C Expression Is Primarily Expressed in Mouse Hematopoietic Stem Cells.

JAM-C/Jam-C Expression Is Primarily Expressed in Mouse Hematopoietic Stem Cells.

Journal: HemaSphere
Published: January 26, 2021

How Hematopoietic Stem Cells Respond to Irradiation: Similarities and Differences between Low and High Doses of Ionizing Radiations.

How Hematopoietic Stem Cells Respond to Irradiation: Similarities and Differences between Low and High Doses of Ionizing Radiations.

Journal: Experimental hematology
Published: August 31, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026